Up-to-date information from the 24.02.-27.02.2025 meeting on new approvals, extensions of indication, newly published EPAR's and recently started procedures.

Recall due to possible contamination with glass splinters

Precautionary batch recall, as there may be glass splinters in the 60 ml bottles

Recall due to deviations from the specified values regarding resuspendability

The Federal Office for Safety in Health Care (BASG) has been informed by the ECDC (European Centre for Disease Prevention and Control) that confirmed autochthonous dengue cases have been recorded in the French overseas territories: Guadeloupe, Martinique, Saint-Martin, Saint-Barthélemy, French Guiana and French Polynesia.

The opportunities of stem cell and other cell-based therapies raise great hopes in physicians as well as patients. Due to novel therapies, major progress is expected particularly in the areas of difficult-to-treat, chronic and incurable diseases. In order to prevent illegal profiteering, it is important for authorities to monitor this quickly evolving therapeutic area.